'We know, from our experience of this virus, that there's something known as long COVID-19, where you have this persistent fatigue and some people have lost their neurological acuteness and they are not as sharp as they used to be.'
Ajit Mishra, vice president, research, Religare Broking, answers your queries.
'Prevention plus vaccination is what is going to take us into better territory by September or October.'
The modalities of COVID-19 vaccine delivery, distribution and administration were discussed during the meeting.
These vaccines have not yet been approved by the World Health Organization
Dr V K Paul, Member (Health) Niti Aayog, who also chairs the national expert group on COVID-19 vaccine administration, said the government attaches 'great importance to this offer of partnership from a very special friend to this nation'.
This will boost availability of these items as well as make them cheaper, it said, adding that Modi also directed the revenue department to ensure seamless and quick custom clearance of such equipment.
In a tweet, Prime Minister Narendra Modi said India is deeply honoured to be a 'long-trusted' partner in meeting the healthcare needs of the global community and that supplies of the vaccines to several countries will commence on Wednesday, and more will follow in the days ahead.
The endemic stage is when a population learns to live with a virus.
The official expressed hope on the success of the five vaccines that are under different phases of trial in the country.
Out of the 447 adverse events following immunisation, only 3 required hospitalisation.
It is estimated the current Indian vaccine market is around $900 million, with a potential to touch $4.6 billion by 2017.
The government is hopeful of a speedy launch of single-dose COVID-19 vaccine Sputnik Light in India and all stakeholders, including the Russian manufacturer and its Indian partners, have been directed to fast-track the application and regulatory approval procedures for the jab to boost the country's vaccination drive, sources said.
While virologists say theoretically the vaccine that works on Delta should work on the Delta Plus variant as well, more research is needed.
As India launches the world's most ambitious and biggest vaccination drive against COVID-19, the country will encounter the formidable challenge of rapidly scaling up distribution of the vaccines to secure immunity for its entire population, two prominent Indian scientists at World Health Organisation have said.
Anybody over 50 years of age or with co-morbidities can get a date, place and time of choice for getting the vaccine shots.
'Whenever you roll out: effectiveness is important, operational logistics are important, side effects are important and vaccine hesitancy is important.'
On Wednesday, the Maharashtra government had said that it would not be able to launch the 18-45 age group vaccination drive from May 1 due to the shortage of vaccines.
Vaccinating 100-200 people in each session per day, monitoring them for 30 minutes after administering the shots for any adverse event and allowing only one beneficiary at a time are among the guidelines issued by the Centre for the COVID-19 inoculation drive.
Union Health Minister Harsh Vardhan on Friday said the COVID-19 vaccination drive will be extended in the coming days and asserted that there should not be any misconceptions about the two Indian vaccines being administered in the country.
The PM-CARES fund, which has been set up to provide relief during the coronavirus pandemic, has contributed over Rs 2,200 crore for the first phase of vaccination drive, which is looking to inoculate frontline healthcare workers, the Expenditure Secretary said on Tuesday.
In phase I, the vaccine would be tested on 375 volunteers and the maximum of 100 of them would be from AIIMS.
In this part, we highlight some of Karnataka's leading entrepreneurs. They are the ones who played a key role in defining its present cosmopolitan status, giving Karnataka a resonance in history and in international relations.
Providing data, it said UK's Public Health England has reported high vaccine effectiveness (87.9 per cent) against the B.1.617.2 variant, most reported in India, in an observational study (concluded on May 22, 2021).
While the vaccine could be available at $3-6 (Rs 225 to Rs 550) per dose, herd immunity might be two years away due to implementation challenges, it said, adding the experience in large scale adult vaccination programmes is thin.
Revival in demand for IPOs has prompted the companies to tap primary market.
Modi is also likely to launch the Co-WIN (COVID Vaccine Intelligence Network) App, a digital platform created for real-time monitoring of COVID-19 vaccine delivery and distribution.
The Indian Council of Medical Research will start national-level sero surveys to assess the spread of Covid-19 and all states/Union territories should also be encouraged to conduct them so that information from all geographies can be collected, the Union health ministry said on Friday.
The remarks come amid suspected cases of COVID-19 reinfection being reported from abroad and from Indian states like Telangana, Karnataka, Gujarat, Punjab and Maharashtra.
In view of the unprecedented and peculiar circumstances under which vaccination drive is devised as an executive policy, the "wisdom of the executive should be trusted", it said.
'The Union government has discouraged state and local governments from imposing restrictions on their own.' 'That advice should be withdrawn,' asserts Mihir S Sharma.
Agri Biotech Foundation, with the mission of promoting Biotechnology, is offering PhD fellowships in agricultural biotechnology and socio-economic aspects of agricultural biotechnology.
The first dry run of the vaccination drive took place across 125 districts covering all States/UTs on January 2. The dry run was also conducted to familiarise the state, district, block, and hospital-level officers on all aspects of the COVID-19 rollout.
India, which allowed commercial cultivation of Bt cotton in 2002, has put moratorium on Bt brinjal since February 2010.
Serum Institute of India CEO Aadar Poonawalla has said that the production of Covid-19 vaccine Covishield is in full swing in Pune and he will review the operations once he is back in the country in a few days. Poonawalla is currently in the UK to meet his family members.
Many are now hoping the markets remain in good stead as they look to finalise the dates for IPOs, such as UTI MF, Computer Age Management Services, Happiest Mind, and Angel Broking. Most of the issues are expected to come to the market in the second half of September.
The Department of Biotechnology invites applications from post-graduates in biotechnology for its six months Biotech Industrial Training Programme 2006-2007.
A steady decline in new COVID-19 cases has been recorded in India for the last 20 days, with 24 states witnessing a dip in active cases since the last week, the Union health ministry said.
Millions of people across the country stayed indoors on March 22, 2020 in an unprecedented and overwhelming response to Prime Minister Narendra Modi's appeal for the nationwide curfew. People used to come out briefly at 5 pm to show their gratitude to healthcare and other essential service providers with sounds of bells, conches and claps.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances